H-1 MR spectroscopy was used to correlate the metabolite-signals in 66
untreated metastatic brain tumors with the results of Gd-DTPA enhance
d MRI, Cubic volumes containing brain metastases of lung cancer (n=17)
, mammary carcinoma (n=24), melanoma (n=12) and those originating from
other tumors (n=13) were examined using the double spin echo techniqu
e with CHESS pulses for water suppression and TE=135 ms, Apart from tr
ends toward reduced signals of choline-containing compounds (Cho) and
reduced post-Gd MRI contrast in lung cancer compared with the other pa
thology groups, the four tumor groups had similar MRI and MRS characte
ristics. Metastases without lipid or lactate (Lact) signal in the H-1
MR spectra were comparatively small in size with homogeneous post-Gd M
RI enhancement (33+/-5%, means+/-SEM; n=24) and elevated Cho signals c
ompared with normal contralateral brain tissue (70+/-5% of contralater
al N-acetyl aspartate signal; p<0.001), The other metastases showed ei
ther unambiguous lipid signals (n=30) or MRS detectable Lact (n=12) an
d were heterogeneous on MRI with divergent signals of Gd-enhancement (
49+/-5% vs 14+/-8%, p<0.001) and Cho (88+/-10 vs 47+/-8% of contralate
ral NAA; p=0.02), Those with Lact were significantly larger compared w
ith both other groups (p<0.02, both). It is concluded that brain metas
tases can be categorized into early stage (Cho), intermediate stage (l
ipid, higher Cho) and late stage metastases (Lact, lower Cho).